Andreas Lindauer
Impact in
- Oncology top 5%
- Metal complexes synthesis and properties
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Modeling and Simulation top 5%
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 3
- Drug Transport and Resistance Mechanisms 3
- Cancer Treatment and Pharmacology 2
- Co-authors
- Ulrich Jaehde (8 shared papers)Rik de Greef (3 shared papers)Jeroen Elassaiss‐Schaap (3 shared papers)Friederike Kanefendt (3 shared papers)Uwe Fuhr (3 shared papers)Oxana Doroshyenko (1 shared paper)Bernhard K. Keppler (2 shared papers)Jürgen Wolf (1 shared paper)
- Journals
- CPT Pharmacometrics & Systems Pharmacology (5 papers)Clinical Pharmacokinetics (3 papers)Therapeutic Drug Monitoring (2 papers)JBIC Journal of Biological Inorganic Chemistry (1 paper)The Journal of Clinical Pharmacology (1 paper)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Andreas Lindauer
18 papers receiving 762 citations
Peers
Comparison fields: 5 of 84
- Oncology 506
- Modeling and Simulation 43
- Hematology 78
- Pharmacology 47
- Organic Chemistry 151
Countries citing papers authored by Andreas Lindauer
This map shows the geographic impact of Andreas Lindauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Lindauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Lindauer more than expected).
Fields of papers citing papers by Andreas Lindauer
This network shows the impact of papers produced by Andreas Lindauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Lindauer. The network helps show where Andreas Lindauer may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Lindauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 210 | |
| 2 | 2011 | 183 | |
| 3 | 2016 | 91 | |
| 4 | 2016 | 83 | |
| 5 | 2016 | 65 | |
| 6 | 2010 | 42 | |
| 7 | 2020 | 21 | |
| 8 | 2015 | 19 | |
| 9 | 2012 | 16 | |
| 10 | 2008 | 15 | |
| 11 | 2012 | 7 | |
| 12 | 2010 | 6 | |
| 13 | 2019 | 6 | |
| 14 | 2017 | 4 | |
| 15 | 2024 | 2 | |
| 16 | 2024 | 2 | |
| 17 | 2004 | 2 | |
| 18 | 2005 | 1 | |
| 19 | 2025 | 0 |
About Andreas Lindauer
Andreas Lindauer is a scholar working on Oncology, Molecular Biology, Cardiology and Cardiovascular Medicine, Pediatrics, Perinatology and Child Health and Organic Chemistry, having authored 19 papers that have together received 775 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Cancer Treatment and Pharmacology (2 papers), Pharmacological Effects and Toxicity Studies (2 papers), Quinazolinone synthesis and applications (2 papers), Pharmaceutical studies and practices (2 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). The work is most often cited by research in Oncology (506 citations), Modeling and Simulation (43 citations), Hematology (78 citations), Pharmacology (47 citations) and Organic Chemistry (151 citations). Andreas Lindauer has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Ulrich Jaehde, Rik de Greef, Jeroen Elassaiss‐Schaap, Friederike Kanefendt, Uwe Fuhr, Oxana Doroshyenko, Bernhard K. Keppler, Jürgen Wolf, Matthias Scheffler and Ralf A. Hilger. Their work appears in journals such as CPT Pharmacometrics & Systems Pharmacology, Clinical Pharmacokinetics, Therapeutic Drug Monitoring, JBIC Journal of Biological Inorganic Chemistry and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.